KalVista Pharmaceuticals (KALV) EPS (2017 - 2026)
KalVista Pharmaceuticals (KALV) EPS from Jan 31, 2017 to Mar 31, 2026. The TTM KalVista Pharmaceuticals (KALV) EPS is -$3.61. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
KalVista Pharmaceuticals (KALV) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -44.15% |
| 3 Years TTM | -8.62% |
| 5 Years TTM | +4.48% |
| All Time TTM | +7.53% |
Annual EPS change of KalVista Pharmaceuticals (KALV)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.46 | -87.56% |
| 2025 | -$3.69 | +23.78% |
| 2024 | -$2.98 | +1.44% |
| 2023 | -$2.94 | -12.46% |
| 2022 | -$3.35 | +77.14% |
| 2021 | -$1.89 | +16.03% |
| 2020 | -$1.63 | +35.41% |
| 2019 | -$1.21 | +294.37% |
| 2018 | -$0.31 | -40.52% |
| 2017 | -$0.51 | N/A |
Comparison KalVista Pharmaceuticals (KALV) five years EPS CAGR with competitors
KalVista Pharmaceuticals (KALV) five years EPS CAGR is 11.29%.